Company intelligence / Profile preview

Therenva

Rennes, Bretagne, Francetherenva.com ↗

Ownership: Private
Development stage: Commercial

Overview

Therenva’s AI-based medical imaging platforms are commercially available and widely used in clinical practice for preoperative planning and intraoperative guidance of minimally invasive cardiovascular procedures. The company’s solutions have been adopted by leading device companies and advanced clinical centers worldwide. Over one million case plans have been performed using their technology. No drug or therapeutic clinical trial results apply.

Therapeutic areas: Cardiovascular
Modalities: DeviceNon-pharmacological therapy
Industry: Medical Imaging

Partnerships

Ziehm Imaginginnovative device companies and advanced clinical centers in endovascular therapy worldwide

Beyond the preview

Go deeper on Therenva.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Therenva.

Explore the full profile